U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 104 results

Status:
US Approved Rx (2008)
First approved in 2008

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Clevidipine is a dihydropyridine calcium channel blocker. Clevidipine is marketed under the trade name Cleviprex, indicated for the reduction of blood pressure (BP) when oral therapy is not feasible or not desirable. Clevidipine is a dihydropyridine ...
Status:
US Approved Rx (2008)
First approved in 1995

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Nisoldipine is a 1,4-dihydropyridine derivative with an outstanding vascular selectivity. As a specific calcium antagonist, it shortens the action potential and causes electromechanical uncoupling in ventricular myocardium. However, this effect, resu...
Status:
US Approved Rx (2010)
First approved in 1991

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium...
Status:
US Approved Rx (2006)
First approved in 1990

Class (Stereo):
CHEMICAL (RACEMIC)


Conditions:

Isradipine (tradenames DynaCirc, Prescal) is a calcium channel blocker of the dihydropyridine class. It is usually prescribed for the treatment of high blood pressure in order to reduce the risk of stroke and heart attack. Except for diuretic activit...
Status:
US Approved Rx (2024)
First approved in 1988

Class (Stereo):
CHEMICAL (RACEMIC)



Nicardipine is a potent calcium channel blockader with marked vasodilator action used to treat high blood pressure and angina. By deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the...
Status:
US Approved Rx (2025)
First approved in 1988

Class (Stereo):
CHEMICAL (RACEMIC)



Nimodipine is a dihydropyridine calcium antagonist which has been shown to dilate cerebral arterioles and increase cerebral blood flow in animals and humans. It has potential in the treatment of a range of cerebrovascular disorders. Major interest to...
Status:
US Approved Rx (2009)
First approved in 1987

Class (Stereo):
CHEMICAL (RACEMIC)



Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle. Experimental data suggest that amlodipine binds...
Status:
US Approved Rx (2020)
First approved in 1982

Class (Stereo):
CHEMICAL (ABSOLUTE)



Diltiazem is a nondihydropyridines calcium channel blocker used in the treatment of hypertension, angina pectoris, and some types of arrhythmia. Diltiazem produces its antihypertensive effect primarily by relaxation of vascular smooth muscle and the ...
Status:
US Approved Rx (2022)
First approved in 1978

Class (Stereo):
CHEMICAL (RACEMIC)



Verapamil is a FDA approved drug used to treat high blood pressure and to control chest pain. Verapamil is an L-type calcium channel blocker that also has antiarrythmic activity. The R-enantiomer is more effective at reducing blood pressure compared ...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)

Elnadipine is a calcium- and calmodulin antagonist exerting activity in the cardiovascular system.